Fewer than one in three people with health insurance receive direct-acting antiviral treatment for hepatitis C within a year of diagnosis, ranging from 23% of Medicaid enrollees to 35% of people with private insurance, according to a report released today by the Centers for Disease Control and Prevention. Adults under 40 had the highest rate of new infections by age, most commonly through injection drug use, but are least likely to receive treatment, CDC said. 

Over 2 million U.S. adults have hepatitis C virus infection, which contributes to about 14,000 deaths a year. Infections are increasing by about 60,000 per year, nearly quadruple the rate a decade ago, largely due to the opioid epidemic, officials said. Eight to 12 weeks of direct-acting antiviral treatment can cure over 95% of cases. Although competition has reduced the net cost of these oral medications, initial treatment costs exceeded $90,000 in 2014, resulting in many insurers establishing restrictions to access, the report notes.

To increase access to treatment, the report recommends ending policies that limit patient eligibility based on fibrosis stage or sobriety and that require treatment through specialists or preauthorization. It also recommends integrating universal hepatitis C screening and simplified treatment protocols into primary care and other settings that serve hepatitis C patients; and expanding the number of primary care providers who treat hepatitis C, especially Medicaid providers serving disproportionately affected populations.

Related News Articles

Headline
President Biden March 13 announced the White House Challenge to Save Lives from Overdose, a national call to action for the public and private sectors to…
Headline
Released during National Eating Disorder Awareness week, the latest AHA People Matter, Words Matter poster encourages compassionate and caring language when…
Headline
The Substance Abuse and Mental Health Services Administration Feb. 8 issued a final rule implementing Coronavirus Aid, Relief, and Economic Security Act…
Headline
The Substance Abuse and Mental Health Services Administration Jan. 31 updated its Overdose Prevention and Response Toolkit, which includes basic information on…
Headline
The Substance Abuse and Mental Health Services Administration Jan. 31 issued a final rule that updates certain regulations for Opioid Treatment Programs and…
Headline
The House Dec. 12 voted 386-37 to pass AHA-supported legislation (H.R. 4531) that would reauthorize key SUPPORT Act programs for patients with substance use…